Lugano, Switzerland (December 04, 2014)

Swiss Medendi succeeded in the semi-final of StartCup Ticino and was selected to participate in the StartCup Ticino final, competing against four other ventures for the Ticino StartCup 2014.

About StartCup Ticino

The StartCup Ticino competition is an initiative of the USI-SUPSI Start-Up Promotion Center (CP Start-Up) aiming at fostering entrepreneurship in Ticino. The purpose of the StartCup Ticino is to reward the most innovative and promising business projects, conceived or realized in Ticino in recent years. The five finalists of the competition will be automatically admitted to the second phase of the selection for the Swiss Economic Award and to the 1st Venture Day Ticino. For more information on the StartCup Ticino, please visit

About Swiss Medendi

Swiss Medendi SA is a Switzerland based start-up company offering a proprietary, cost-efficient and easy-to-use intravenous (IV) infusion device, the HC100, for safe administration of chemotherapeutics and other vesicant and irritant drugs – protecting patients’ veins and vessels from vesicant damages, and preventing patients from injuries and complications associated today with ports and catheters. Employing the HC100 will help hospitals to manage costs and enable doctors to focus more on their patients’ needs. For more information on Swiss Medendi, please visit